InvestorsHub Logo
Post# of 252478
Next 10
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

Re: biomaven0 post# 191446

Tuesday, 05/19/2015 1:29:09 PM

Tuesday, May 19, 2015 1:29:09 PM

Post# of 252478
FGEN / ENTA:

And what number do you plan to use for "Y" that makes this easier?



What I was trying to convey is that, from my conversations, the factors that will go into roxa treatment (and duration) in an end-stage renal disease patient are more nuanced than treating someone with an HCV antiviral. Duration of treatment and the ways docs will optimally work roxa into their treatment are more complicated (and less predictable imo) than for the antivirals.

Easier was the wrong word. Both are challenging, but one is less so imo.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.